title: In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
authors.forename: M A
authors.initials: MA
authors.lastname: Croco
authors.forename: D J
authors.initials: DJ
authors.lastname: Biedenbach
authors.forename: M A
authors.initials: MA
authors.lastname: Pfaller
authors.forename: G V
authors.initials: GV
authors.lastname: Doern
authors.forename: R N
authors.initials: RN
authors.lastname: Jones
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology*; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D006801:Humans; D007875:Legionella / Q000187:drug effects* / Q000302:isolation & purification; D016952:Legionella pneumophila / Q000187:drug effects / Q000302:isolation & purification; D007876:Legionellosis / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D009287:Naphthyridines / Q000494:pharmacology*; D015363:Quinolones / Q000494:pharmacology*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D015363:Quinolones; C080163:trovafloxacin; D000077734:Gatifloxacin; C061363:sparfloxacin